A miRNAome-guided pathway analysis, in fact, defined two transcriptional signatures associated with EphB2 cells/early CRC phases and EphA2 cells/late CRC phases, with significant prognostic value. The gene discussed is EPHB2; the disease is colorectal carcinoma.